Dietary Advanced Glycation End Products and Migraine

Is dietary intake of advanced glycation different between individuals with and without migraine? Is there a difference between the groups in terms of energy and nutrients? The answers to these questions are sought.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nutrition Disorders Brain Diseases Central Nervous System Diseases Headache Disorders Headache Disorders, Primary Migraine Disorders Nervous System Diseases Nutritional and Metabolic Diseases

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Karabuk University

Karabük, 78050, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

To be diagnosed with episodic migraine by an experienced neurologist,
For the control group, patients who were not diagnosed with migraine but applied to the headache outpatient clinic
Volunteer

Exclusion criteria

Being younger than 19 years and older than 64 years of age, having a history of cardiovascular disease, hypertension, diabetes, cancer, liver and kidney disease or other neurological disorder (epilepsy, multiple sclerosis, stroke, traumatic brain injury, etc.), secondary headache, antilipidemic and glucose taking intolerance medications or vitamin-mineral supplements, following a special diet, and consuming less than 800 kcal or more than 4000 kcal per day

Treatment and study plan

Primary outcomes

Difference in dietary advanced glycation end products intake between groups

Time frame: 2 months

Is there a difference between the dietary intake of advanced glycation end products in individuals with migraine and healthy individuals? These values will be obtained from the food consumption records of the individuals. Intake of advanced glycation end product will be evaluated as ....kU/day.

Is there a difference between the energy and nutrient intake of individuals with migraine and healthy individuals?

Sponsors and collaborators

Lead sponsor

Karabuk University

Other

Registry information

Official study title

Are Dietary Intake of Advanced Glycation End Products and Migraine Associated? A Case-control Study

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2023
First posted: Feb 28, 2023
Registry last updated: May 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed